RNAi Technology Market Share Analysis, Trends, Segmentation, Top Players Analysis, Growth and COVID-19 Impact Forecast by 2020-2026

(Profound via Comtex)

A recent report provides crucial insights along with application based and forecast information in the Global RNAi Technology Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the RNAi Technology market.

With increasing cases of obesity all over the globe, a need for conducting an in-depth study about this healthcare issue led to the development of this report. Increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress, are key market drivers. The report discusses more information about these subjects, with a focus on the rising need for RNAi Technology.

Download Sample - https://www.qyresearchmedical.com/sample/81946

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period. With healthcare being a sensitive topic, a separate analysis is included that discusses the widespread continuing obesity all over the globe consequently increasing demand for surgical devices.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analyzed and prime business strategies and products that offer high revenue generation capacities were indentified. Key players of the global RNAi Technology market are included as given below:

Alnylam Pharmaceuticals
Dicerna Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma
Calando
Silence Therapeutics
Gotham Therapeutics

By the therapy area, the market is primarily split into
Cancer
Liver Disorders
Respiratory Disorders
Neurological Disorders
Autoimmune Disorders
Others
By the application, this report covers the following segments
Drug Discovery amp; Development
Therapeutics
Drug Delivery
Others

Download Full Report - https://www.qyresearchmedical.com/report/checkout/81946/3500

Reasons to Purchase this Report:

  • Estimates RNAi Technology development trends with SWOT analysis
  • Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players
  • Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion
  • Market dynamics and opportunities for growth for players in the near future
  • Competitive landscape describing the RNAi Technology market revenue shares of key players.
  • Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects

TABLE OF CONTENT

1 Market Overview of RNAi Technology
1.1 RNAi Technology Market Overview
1.1.1 RNAi Technology Product Scope
1.1.2 Market Status and Outlook
1.2 Global RNAi Technology Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global RNAi Technology Market Size by Region (2015-2026)
1.4 Global RNAi Technology Historic Market Size by Region (2015-2020)
1.5 Global RNAi Technology Market Size Forecast by Region (2021-2026)
1.6 Covid-19 Impact on Key Regions, RNAi Technology Market Size YoY Growth (2015-2026)
1.6.1 North America RNAi Technology Market Size YoY Growth (2015-2026)
1.6.2 Europe RNAi Technology Market Size YoY Growth (2015-2026)
1.6.3 China RNAi Technology Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific RNAi Technology Market Size YoY Growth (2015-2026)
1.6.5 Latin America RNAi Technology Market Size YoY Growth (2015-2026)
1.6.6 Middle East amp; Africa RNAi Technology Market Size YoY Growth (2015-2026)
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy

2 Covid-19 Impact on RNAi Technology Market Overview by Therapy Area
2.1 Global RNAi Technology Market Size by Therapy Area: 2015 VS 2020 VS 2026
2.2 Global RNAi Technology Historic Market Size by Therapy Area (2015-2020)
2.3 Global RNAi Technology Forecasted Market Size by Therapy Area (2021-2026)
2.4 Cancer
2.5 Liver Disorders
2.6 Respiratory Disorders
2.7 Neurological Disorders
2.8 Autoimmune Disorders
2.9 Others

3 Covid-19 Impact on RNAi Technology Market Overview by Application
3.1 Global RNAi Technology Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global RNAi Technology Historic Market Size by Application (2015-2020)
3.3 Global RNAi Technology Forecasted Market Size by Application (2021-2026)
3.4 Drug Discovery amp; Development
3.5 Therapeutics
3.6 Drug Delivery
3.7 Others

4 Covid-19 Impact on Global RNAi Technology Competition Analysis by Players
4.1 Global RNAi Technology Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNAi Technology as of 2019)
4.3 Date of Key Manufacturers Enter into RNAi Technology Market
4.4 Global Top Players RNAi Technology Headquarters and Area Served
4.5 Key Players RNAi Technology Product Solution and Service
4.6 Competitive Status
4.6.1 RNAi Technology Market Concentration Rate
4.6.2 Mergers amp; Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Alnylam Pharmaceuticals
5.1.1 Alnylam Pharmaceuticals Profile
5.1.2 Alnylam Pharmaceuticals Main Business and Company's Total Revenue
5.1.3 Alnylam Pharmaceuticals Products, Services and Solutions
5.1.4 Alnylam Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.1.5 Alnylam Pharmaceuticals Recent Development and Reaction to Covid-19
5.2 Dicerna Pharmaceuticals, Inc.
5.2.1 Dicerna Pharmaceuticals, Inc. Profile
5.2.2 Dicerna Pharmaceuticals, Inc. Main Business and Company's Total Revenue
5.2.3 Dicerna Pharmaceuticals, Inc. Products, Services and Solutions
5.2.4 Dicerna Pharmaceuticals, Inc. Revenue (US$ Million) (2015-2020)
5.2.5 Dicerna Pharmaceuticals, Inc. Recent Development and Reaction to Covid-19
5.3 Arrowhead Pharmaceuticals, Inc.
5.5.1 Arrowhead Pharmaceuticals, Inc. Profile
5.3.2 Arrowhead Pharmaceuticals, Inc. Main Business and Company's Total Revenue
5.3.3 Arrowhead Pharmaceuticals, Inc. Products, Services and Solutions
5.3.4 Arrowhead Pharmaceuticals, Inc. Revenue (US$ Million) (2015-2020)
5.3.5 Ionis Pharmaceuticals, Inc. Recent Development and Reaction to Covid-19
5.4 Ionis Pharmaceuticals, Inc.
5.4.1 Ionis Pharmaceuticals, Inc. Profile
5.4.2 Ionis Pharmaceuticals, Inc. Main Business and Company's Total Revenue
5.4.3 Ionis Pharmaceuticals, Inc. Products, Services and Solutions
5.4.4 Ionis Pharmaceuticals, Inc. Revenue (US$ Million) (2015-2020)
5.4.5 Ionis Pharmaceuticals, Inc. Recent Development and Reaction to Covid-19
5.5 Quark Pharmaceuticals, Inc.
5.5.1 Quark Pharmaceuticals, Inc. Profile
5.5.2 Quark Pharmaceuticals, Inc. Main Business and Company's Total Revenue
5.5.3 Quark Pharmaceuticals, Inc. Products, Services and Solutions
5.5.4 Quark Pharmaceuticals, Inc. Revenue (US$ Million) (2015-2020)
5.5.5 Quark Pharmaceuticals, Inc. Recent Development and Reaction to Covid-19
5.6 Arbutus Biopharma
5.6.1 Arbutus Biopharma Profile
5.6.2 Arbutus Biopharma Main Business and Company's Total Revenue
5.6.3 Arbutus Biopharma Products, Services and Solutions
5.6.4 Arbutus Biopharma Revenue (US$ Million) (2015-2020)
5.6.5 Arbutus Biopharma Recent Development and Reaction to Covid-19
5.7 Benitec Biopharma
5.7.1 Benitec Biopharma Profile
5.7.2 Benitec Biopharma Main Business and Company's Total Revenue
5.7.3 Benitec Biopharma Products, Services and Solutions
5.7.4 Benitec Biopharma Revenue (US$ Million) (2015-2020)
5.7.5 Benitec Biopharma Recent Development and Reaction to Covid-19
5.8 Calando
5.8.1 Calando Profile
5.8.2 Calando Main Business and Company's Total Revenue
5.8.3 Calando Products, Services and Solutions
5.8.4 Calando Revenue (US$ Million) (2015-2020)
5.8.5 Calando Recent Development and Reaction to Covid-19
5.9 Silence Therapeutics
5.9.1 Silence Therapeutics Profile
5.9.2 Silence Therapeutics Main Business and Company's Total Revenue
5.9.3 Silence Therapeutics Products, Services and Solutions
5.9.4 Silence Therapeutics Revenue (US$ Million) (2015-2020)
5.9.5 Silence Therapeutics Recent Development and Reaction to Covid-19
5.10 Gotham Therapeutics
5.10.1 Gotham Therapeutics Profile
5.10.2 Gotham Therapeutics Main Business and Company's Total Revenue
5.10.3 Gotham Therapeutics Products, Services and Solutions
5.10.4 Gotham Therapeutics Revenue (US$ Million) (2015-2020)
5.10.5 Gotham Therapeutics Recent Development and Reaction to Covid-19

6 North America RNAi Technology by Players and by Application
6.1 North America RNAi Technology Market Size and Market Share by Players (2015-2020)
6.2 North America RNAi Technology Market Size by Application (2015-2020)

7 Europe RNAi Technology by Players and by Application
7.1 Europe RNAi Technology Market Size and Market Share by Players (2015-2020)
7.2 Europe RNAi Technology Market Size by Application (2015-2020)

8 China RNAi Technology by Players and by Application
8.1 China RNAi Technology Market Size and Market Share by Players (2015-2020)
8.2 China RNAi Technology Market Size by Application (2015-2020)

9 Rest of Asia Pacific RNAi Technology by Players and by Application
9.1 Rest of Asia Pacific RNAi Technology Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific RNAi Technology Market Size by Application (2015-2020)

10 Latin America RNAi Technology by Players and by Application
10.1 Latin America RNAi Technology Market Size and Market Share by Players (2015-2020)
10.2 Latin America RNAi Technology Market Size by Application (2015-2020)

11 Middle East amp; Africa RNAi Technology by Players and by Application
11.1 Middle East amp; Africa RNAi Technology Market Size and Market Share by Players (2015-2020)
11.2 Middle East amp; Africa RNAi Technology Market Size by Application (2015-2020)

12 RNAi Technology Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter's Five Forces Analysis

13 Research Finding /Conclusion

14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List

Download Full Report - https://www.qyresearchmedical.com/report/checkout/81946/3500

Contact Us:

QYResearch Medical

URL - http://www.qyresearchmedical.com/

Mailing Address : Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Any Assistance, Email ndash; [email protected]

comtex tracking